Your Call: What’s the process involved in determining what drugs get made and how much they'll cost?
On the August 18th edition of Your Call, we’ll have a conversation about efforts to use experimental drugs to combat the Ebola virus in West Africa. What are the implications of using experimental drugs? How do drugs move from the experimental stage to full approval? What are other ways we can regulate and support research for new drugs? Join the conversation on the next Your Call, with Rose Aguilar and you.
Alta Charo, Warren P. Knowles Professor of Law and Bioethics at the University of Wisconsin at Madison
Peter Katona, clinical professor of Medicine in Infectious Diseases at the David Geffen School of Medicine at UCLA
Stephanie Lee, staff reporter for the San Francisco Chronicle
SF Chronicle: Why Ebola remains a disease without a drug
Boston Globe: Three in Liberia given scarce Ebola drug
The Irish Times: Cui bono? Ebola crisis brings black-and-white question into focus